These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 10921528)

  • 1. The sympathetic system and hypertension.
    Esler M
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):99S-105S. PubMed ID: 10921528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease.
    Esler M; Kaye D
    J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S1-7. PubMed ID: 11346214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural mechanisms in human obesity-related hypertension.
    Rumantir MS; Vaz M; Jennings GL; Collier G; Kaye DM; Seals DR; Wiesner GH; Brunner-La Rocca HP; Esler MD
    J Hypertens; 1999 Aug; 17(8):1125-33. PubMed ID: 10466468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion.
    Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
    J Hypertens; 2004 Aug; 22(8):1529-34. PubMed ID: 15257176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.
    Esler M; Lambert G; Brunner-La Rocca HP; Vaddadi G; Kaye D
    Acta Physiol Scand; 2003 Mar; 177(3):275-84. PubMed ID: 12608997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion].
    Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
    Arch Mal Coeur Vaiss; 2004; 97(7-8):786-92. PubMed ID: 15506067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
    Esler M
    J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.
    Vaz M; Jennings G; Turner A; Cox H; Lambert G; Esler M
    Circulation; 1997 Nov; 96(10):3423-9. PubMed ID: 9396437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.
    Gudbjörnsdottir S; Friberg P; Elam M; Attvall S; Lönnroth P; Wallin BG
    Blood Press; 1994 Nov; 3(6):394-403. PubMed ID: 7704288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction?
    Esler M; Rumantir M; Kaye D; Lambert G
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):139S-146S. PubMed ID: 11411749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, hypertension, and sympathetic nervous system activity.
    Corry DB; Tuck ML
    Curr Hypertens Rep; 1999; 1(2):119-26. PubMed ID: 10981052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension.
    Krum H; Lambert E; Windebank E; Campbell DJ; Esler M
    Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1706-12. PubMed ID: 16284232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of rilmenidine on neurogenic hypertension in BPH/2J genetically hypertensive mice.
    Jackson KL; Palma-Rigo K; Nguyen-Huu TP; Davern PJ; Head GA
    J Hypertens; 2014 Mar; 32(3):575-86. PubMed ID: 24275840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy.
    Schlaich MP; Kaye DM; Lambert E; Sommerville M; Socratous F; Esler MD
    Circulation; 2003 Aug; 108(5):560-5. PubMed ID: 12847071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic and baroreflex function in hypertension: implications for current and new drugs.
    Grassi G
    Curr Pharm Des; 2004; 10(29):3579-89. PubMed ID: 15579055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympatho-adrenal mechanisms regulating cardiovascular hypertrophy in primary hypertension: a role for rilmenidine?
    Bobik A; Dilley R; Kanellakis P
    J Hypertens Suppl; 1998 Aug; 16(3):S51-4. PubMed ID: 9747911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.